Xentry-Gap-19

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameXentry-Gap-19
Drug Alias NameXentry-Gap19Xentry-Gap-19
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGap junction alpha-1 protein agonists
TargetsGap junction alpha-1 protein
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Auckland
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A